Related references
Note: Only part of the references are listed.Estimation of clinical trial success rates and related parameters
Chi Heem Wong et al.
BIOSTATISTICS (2019)
Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer
Le Zhang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Senolytics and senostatics as adjuvant tumour therapy
Susan Short et al.
EBIOMEDICINE (2019)
CELLULAR SENESCENCE: AGING, CANCER, AND INJURY
Arianna Calcinotto et al.
PHYSIOLOGICAL REVIEWS (2019)
Senolytic therapies for healthy longevity
Jan M. van Deursen
SCIENCE (2019)
A novel UCHL3 inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair
Zhiwang Song et al.
CELL DEATH & DISEASE (2019)
Pharmacological boost of DNA damage response and repair by enhanced biogenesis of DNA damage response RNAs
Ubaldo Gioia et al.
SCIENTIFIC REPORTS (2019)
The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors
Aubrey L. Miller et al.
EBIOMEDICINE (2019)
Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Miren Taberna et al.
FRONTIERS IN ONCOLOGY (2019)
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial
Ramesh Rengan et al.
JAMA ONCOLOGY (2019)
State-of-the-art strategies for targeting the DNA damage response in cancer
Patrick G. Pilie et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response
Ayala Gold et al.
ONCOGENE (2019)
Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases
Prashanta Kumar Panda et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
HMG-CoA Reductase Inhibition Delays DNA Repair and Promotes Senescence After Tumor Irradiation
Elena V. Efimova et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer
Sana D. Karam et al.
CLINICAL CANCER RESEARCH (2018)
Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment
Xiao-Tang Kong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Repair of DNA double-strand breaks by mammalian alternative end-joining pathways
Annahita Sallmyr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance
Yu Shi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Two-Step Senescence-Focused Cancer Therapies
Cynthia J. Sieben et al.
TRENDS IN CELL BIOLOGY (2018)
Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib
Stephanie Hehlgans et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
ReDO_DB: the repurposing drugs in oncology database
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2018)
Mechanisms and therapeutic significance of autophagy modulation by antipsychotic drugs
Ljubica Vucicevic et al.
CELL STRESS (2018)
Modulating DNA Repair Pathways to Improve Precision Genome Engineering
Katherine S. Pawelczak et al.
ACS CHEMICAL BIOLOGY (2018)
Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells
Delphine Guillotin et al.
CLINICAL CANCER RESEARCH (2017)
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy
Lorenzo Galluzzi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells
Kirk Jensen et al.
ENDOCRINE-RELATED CANCER (2017)
Autophagy Roles in the Modulation of DNA Repair Pathways
Luciana R. Gomes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery
Juhong Jiang et al.
INVESTIGATIONAL NEW DRUGS (2017)
Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment
Go J. Yoshida
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
The Clinical Potential of Senolytic Drugs
James L. Kirkland et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
Andrew N. Blackford et al.
MOLECULAR CELL (2017)
Charged-particle therapy in cancer: clinical uses and future perspectives
Marco Durante et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Non-homologous DNA end joining and alternative pathways to double-strand break repair
Howard H. Y. Chang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord et al.
SCIENCE (2017)
Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition
Lu Yang et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Identification of HSP90 inhibitors as a novel class of senolytics
Heike Fuhrmann-Stroissnigg et al.
NATURE COMMUNICATIONS (2017)
Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice
Patrick M. Reeves et al.
ONCOTARGET (2017)
Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparib
Atsushi Osoegawa et al.
ONCOTARGET (2017)
Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC)
Fugui Zhang et al.
ONCOTARGET (2017)
High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer
Liqin Wang et al.
CELL REPORTS (2017)
Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells
Guoling Li et al.
SCIENTIFIC REPORTS (2017)
Curcumin enhances the radiosensitivity of renal cancer cells by suppressing NF-κB signaling pathway
Gang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Targeting Metabolism for Cancer Therapy
Alba Luengo et al.
CELL CHEMICAL BIOLOGY (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
Genome Organization Drives Chromosome Fragility
Andres Canela et al.
CELL (2017)
Senescence in Health and Disease
Shenghui He et al.
CELL (2017)
New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463
Yi Zhu et al.
AGING-US (2017)
Linking Cancer Metabolism to DNA Repair and Accelerated Senescence
Elena V. Efimova et al.
MOLECULAR CANCER RESEARCH (2016)
Small molecule compounds that induce cellular senescence
Nadezhda V. Petrova et al.
AGING CELL (2016)
Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors
Yi Zhu et al.
AGING CELL (2016)
A Novel Chemotherapeutic Agent to Treat Tumors with DNA Mismatch Repair Deficiencies
Yongliang Zhang et al.
CANCER RESEARCH (2016)
Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?
Brian Budke et al.
CHEMMEDCHEM (2016)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer
James M. Wilson et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Nuclear physics in particle therapy: a review
Marco Durante et al.
REPORTS ON PROGRESS IN PHYSICS (2016)
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
Reut Yosef et al.
NATURE COMMUNICATIONS (2016)
Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers
Edwardine Labay et al.
ONCOTARGET (2016)
The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
Michael Goldstein et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Small Molecules Enhance CRISPR Genome Editing in Pluripotent Stem Cells
Chen Yu et al.
CELL STEM CELL (2015)
Targeting Mitosis in Cancer: Emerging Strategies
Carmen Dominguez-Brauer et al.
MOLECULAR CELL (2015)
Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer
Muhammad Ary Zucha et al.
Oncotarget (2015)
Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC
Yuan Hu et al.
APOPTOSIS (2014)
Combined autophagy and HDAC inhibition A phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors
Devalingam Mahalingam et al.
AUTOPHAGY (2014)
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
Reshma Rangwala et al.
AUTOPHAGY (2014)
Combined MTOR and autophagy inhibition Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma
Reshma Rangwala et al.
AUTOPHAGY (2014)
A Small Molecule Screen Identifies an Inhibitor of DNA Repair Inducing the Degradation of TFIIH and the Chemosensitization of Tumor Cells to Platinum
Sergey Alekseev et al.
CHEMISTRY & BIOLOGY (2014)
Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer
Panagiotis A. Konstantinopoulos et al.
GYNECOLOGIC ONCOLOGY (2014)
Chemical con artists foil drug discovery
Jonathan Baell et al.
NATURE (2014)
Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
Understanding nucleotide excision repair and its roles in cancer and ageing
Jurgen A. Marteijn et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
A high-throughput chemical screen with FDA approved drugs reveals that the antihypertensive drug Spironolactone impairs cancer cell survival by inhibiting homology directed repair
Or David Shahar et al.
NUCLEIC ACIDS RESEARCH (2014)
Chromatin modifications and DNA repair: beyond double-strand breaks
Nealia C. M. House et al.
FRONTIERS IN GENETICS (2014)
Drugging Topoisomerases: Lessons and Challenges
Yves Pommier
ACS CHEMICAL BIOLOGY (2013)
Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity
Brendon Ladd et al.
DNA REPAIR (2013)
Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells
Tetsuya Tamatani et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
A Small Molecule Inhibitor of Polycomb Repressive Complex 1 Inhibits Ubiquitin Signaling at DNA Double-strand Breaks
Ismail Hassan Ismail et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Charged particle therapy-optimization, challenges and future directions
Jay S. Loeffler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
Michael L. Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
Kyle R. Cron et al.
PLOS ONE (2013)
Cancer and Radiation Therapy: Current Advances and Future Directions
Rajamanickam Baskar et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2012)
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
Celine Jacquemont et al.
MOLECULAR CANCER (2012)
Balancing repair and tolerance of DNA damage caused by alkylating agents
Dragony Fu et al.
NATURE REVIEWS CANCER (2012)
Bortezomib-induced BRCAness sensitizes multiple myeloma cells to PARP inhibitors
Paola Neri et al.
BLOOD (2011)
IMPROVED BIOCHEMICAL OUTCOMES WITH STATIN USE IN PATIENTS WITH HIGH-RISK LOCALIZED PROSTATE CANCER TREATED WITH RADIOTHERAPY
Marisa A. Kollmeier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Spindle Poisons and Cell Fate: A Tale of Two Pathways
Daniel R. Matson et al.
MOLECULAR INTERVENTIONS (2011)
Targeting inflammatory pathways for tumor radiosensitization
Amit Deorukhkar et al.
BIOCHEMICAL PHARMACOLOGY (2010)
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier et al.
CHEMISTRY & BIOLOGY (2010)
Epigenetic Modifications in Double-Strand Break DNA Damage Signaling and Repair
Dorine Rossetto et al.
CLINICAL CANCER RESEARCH (2010)
STAT3 modulates the DNA damage response pathway
Sean P. Barry et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2010)
Statin Use and Risk of Prostate Cancer Recurrence in Men Treated With Radiation Therapy
Ruchika Gutt et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The DNA Damage Response: Making It Safe to Play with Knives
Alberto Ciccia et al.
MOLECULAR CELL (2010)
A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model
Andrey S. Tsvetkov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PARP inhibition: PARP1 and beyond
Michele Rouleau et al.
NATURE REVIEWS CANCER (2010)
How the Fanconi Anemia Pathway Guards the Genome
George-Lucian Moldovan et al.
ANNUAL REVIEW OF GENETICS (2009)
Mechanism of eukaryotic homologous recombination
Joseph San Filippo et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
The DNA damage response: Ten years after
J. Wade Harper et al.
MOLECULAR CELL (2007)
HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination
Shanthi Adimoolam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Small molecule regulators of autophagy identified by an image-based high-throughput screen
Lihong Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nelfinavir, a lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo
JoellJ. Gills et al.
CLINICAL CANCER RESEARCH (2007)
Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-β, and Bcl-2
Maria Hoyer-Hansen et al.
MOLECULAR CELL (2007)
The multifaceted mismatch-repair system
J Jiricny
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway
D Chirnomas et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Free radicals, metals and antioxidants in oxidative stress-induced cancer
M Valko et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo
AK Gupta et al.
CANCER RESEARCH (2005)
Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity
K Dittmann et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Cellular DNA replicases: Components and dynamics at the replication fork
A Johnson et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2005)
Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine
WD Block et al.
NUCLEIC ACIDS RESEARCH (2004)
DNA double-strand breaks: signaling, repair and the cancer connection
KK Khanna et al.
NATURE GENETICS (2001)
The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01
PR Graves et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
